Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

VandenBussche CJ, Nwosu A, Souers R, Sundling KE, Brainard J, Goyal A, et al. The Implementation of Nongynecologic Reporting Systems in Cytopathology Laboratories Is Highly Variable: Analysis of Data From a 2020 Supplemental Survey of Participants in the College of American Pathologists Interlaboratory Comparison Program in . Arch Pathol Lab Med. 2024;148(5):531-537.

Centeno BA, Saieg M, Siddiqui MT, Perez-Machado M, Layfield LJ, Weynand B, et al. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Overview and Summary. Cancer Cytopathol. 2024;132(7):396-418.

Zehir A, Nardi V, Konnick EQ, Lockwood CM, Long TA, Sidiropoulos N, et al. SPOT/Dx Pilot Reanalysis and College of American Pathologists Proficiency Testing for KRAS and NRAS Demonstrate Excellent Laboratory Performance. Arch Pathol Lab Med. 2024;148(2):139-148.

Omar M, Xu Z, Rand SB, Alexanderani MK, Salles DC, Valencia I, et al. Semi-Supervised, Attention-Based Deep Learning for Predicting TMPRSS2:ERG Fusion Status in Prostate Cancer Using Whole Slide Images. Mol Cancer Res. 2024;22(4):347-359.

Min J, Zaslavsky A, Fedele G, McLaughlin SK, Reczek EE, De Raedt T, et al. Author Correction: An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB. Nat Med. 2024.

Chen C, Fahmy LM, Schreidah CM, Magro CM, Geskin LJ. Febrile Ulceronecrotic Mucha-Habermann Disease Associated With Hemophagocytic Lymphohistiocytosis: A Case Report and Review of the Literature. Am J Dermatopathol. 2024;46(4):238-242.

Magro CM, Sanders S. Tumor necrosis factor ALPHA Inhibitor Associated Köhlmeier-Degos Disease as a Novel Iatrogenic Paradigm That Underscores Excessive Type I Interferon in Its Pathogenesis. Am J Dermatopathol. 2024;46(9):605-610.

Zhang BX, Brantley KD, Rosenberg SM, Kirkner GJ, Collins LC, Ruddy KJ, et al. Second primary non-breast cancers in young breast cancer survivors. Breast Cancer Res Treat. 2024;207(3):587-597.

Liu Y-, Geyer JT. Pediatric Hematopathology in the Era of Advanced Molecular Diagnostics: What We Know and How We Can Apply the Updated Classifications. Pathobiology. 2024;91(1):30-44.

Ondracek CR, Melanson SE, Doan L, Schulz KM, Kleinman S, Zhao Z, et al. Large-Scale Scientific Study Led by a Professional Organization during the COVID-19 Pandemic: Operations, Best Practices, and Lessons Learned. J Appl Lab Med. 2024;9(2):371-385.